LSD (acetaat)

LSD acetate is a peptide. LSD acetate can specifically recognize the lymphatics of C8161 melanoma, but it does not bind to the lymphatics of normal tissues or tumor blood vessels. When conjugated with a proapoptotic peptide, LSD acetate can reduce the number of tumor lymphatics. LSD acetate can be used in the research of targeted therapy and diagnosis of tumor lymphatics[1].

12352209

Biochemical Assay Reagents

Others

Cancer-programmed cell death

Cancer

98.02

DMSO : 100 mg/mL (ultrasonic)

O=C(N[C@@H](CC(C)C)C(N[C@@H](CO)C(N[C@@H](CC(O)=O)C(NCC(N[C@@H](CCCCN)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCCN)C(N[C@@H](CS)C(O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CS)N.CC(O)=O.[x]

C39H72N14O13S2.xC2H4O2

1009.20 (free base)

[1]Zhang L, et al. Lymphatic zip codes in premalignant lesions and tumors. Cancer Res. 2006 Jun 1;66 (11) :5696-706.

Blue Ice

-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

http://file.medchemexpress.com/batch_PDF/HY-P4091A/LSD-acetate-SDS-MedChemExpress.pdf

Peptides

Phase 2